Could Masitinib for dogs be next for humans?

[Guest guest]

" Masitinib is the most advanced drug in the pipeline. Now being marketed in

veterinary medicine, masitinib is also under development in humans, with phase 3

clinical studies in pancreatic cancer and in gastrointestinal stromal tumour

(GIST). This registration in veterinary medicine is good news for the future

success of masitinib in humans, for whom we are aggressively developing it in

cancers and other indications with high morbidity or pain " , explains Alain

Moussy. " It is very unusual to develop such an innovative product simultaneously

in veterinary and human medicines, and even more so that the product is

registered in veterinary medicine first. There is no doubt that experts in human

oncology will be watching Masivet's future very closely from now on. However,

people will have to wait a little while before benefiting from masitinib,

because it is unlikely to be available to man before 2012 " .

Seems as though this drug could have a long life in treatment of several chronic

diseases in trials.

http://www.medicalnewstoday.com/articles/155573.php

http://clinicaltrials.gov/ct2/show/NCT00814073

http://arthritis-research.com/content/11/3/R95

http://www.abstracts2view.com/aan2009seattle/view.php?nu=AAN09L_P06.130

FYI,

Lottie